KING OF PRUSSIA, Pa., April 23, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the following conferences:
Tuesday, May 14, 2024, at 8:00am (ET) at the 2024 RBC Capital Markets Global Healthcare Conference in New York, New York
Wednesday, May 29, 2024, at 2:20pm (CT)/3:20pm (ET) at the 2024 Leerink Partners Healthcare Crossroads Conference in Austin, Texas
Live audio webcasts of the presentations will be available on the Company's website (www.uhs.com). For those unable to listen to the live webcast, replays of the presentations will be available on the Company's website for 90 days following the conferences.
Universal Health Services, Inc. ("UHS") is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico and the United Kingdom.
| Last Trade: | US$165.44 |
| Daily Change: | 2.62 1.61 |
| Daily Volume: | 1,608,782 |
| Market Cap: | US$9.460B |
March 11, 2025 February 26, 2025 | |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
